Pyoderma Gangrenosum Following Initiation of Immune Checkpoint Inhibitor Therapy
Pyoderma gangrenosum (PG) is an ulcerating neutrophilic dermatosis that is often associated with the underlying systemic disease. For example, PG is often a common presenting symptom in patients with hematologic malignancies, most commonly myelodysplastic syndrome (MDS). Here, we present the case of...
Main Authors: | Macartney E Welborn, Shelby L Kubicki, Anisha B Patel |
---|---|
Format: | Article |
Language: | English |
Published: |
Innovative Healthcare Institute
2018-10-01
|
Series: | Journal of Immunotherapy and Precision Oncology |
Subjects: | |
Online Access: | https://jipo.org/doi/pdf/10.4103/JIPO.JIPO_11_18 |
Similar Items
-
Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case
by: Malkan UY, et al.
Published: (2016-03-01) -
Pyoderma gangrenosum in a cesarean section wound in a woman with myelodysplastic syndrome: A case report
by: Nanao Suzuki, et al.
Published: (2020-10-01) -
A case with pyoderma gangrenosum, after an abdominal surgery
by: Gulbahar Sarac, et al.
Published: (2019-06-01) -
Pyoderma gangrenosum with splenic abscess- A rare association
by: Aditi Bansal, et al.
Published: (2022-01-01) -
PYODERMA GANGRENOSUM: A MINI-REVIEW
by: Aristóteles Rosmaninho, et al.
Published: (2015-11-01)